0.00Open0.00Pre Close0 Volume0 Open Interest13.50Strike Price0.00Turnover0.00%IV-21.88%PremiumJul 12, 2024Expiry Date3.78Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.64Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Teva Pharmaceutical Industries Stock Discussion
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
loading...
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
No comment yet